Skip to main content
An official website of the United States government

A Virtual Support Platform to Improve Well-Being and Quality of Life in Men with Testicular Cancer, VITALSS Study - AIM 2

Trial Status: approved

This clinical trial compares the effectiveness of a virtual support platform to patient education material to improve well-being and quality of life in men with testicular cancer. Testicular cancer is the most common cancer among men aged 18-39 in the United States. While over 95% will be cured, most patients will experience disease- or treatment-related disability that impacts physical and mental health and quality of life. Even surveillance requires an intense schedule of visits and testing that can negatively affect finances, lifestyle, work/school, and mental health. Peer support and navigation have emerged as potential mechanisms to help patients through cancer care. At the same time, cancer survivors have turned to online spaces and other forums. However, both these models face limitations in testicular cancer. Using a virtual platform that digitally delivers lay support and navigation responsive to the specific needs of testicular cancer survivors may improve patient well-being and quality of life.